UniSuper Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
UniSuper Management's RMD Position: Q3 2026 in Review
UniSuper Management increased its ResMed (RMD) stake by 29% in Q3 2026, buying an estimated $4.77M and bringing the position to 96,562 shares worth $21.3M. The position accounts for 0.1% of the portfolio, ranked #130.
UniSuper Management first reported a position in RMD in Q2 2023 and has held it in 14 quarters since. 280 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- UniSuper Management held 96,562 shares of ResMed worth $21.3M as of Q3 2026.
- UniSuper Management bought 21,870 ResMed shares in Q3 2026, an estimated $4.77M.
- ResMed made up 0.1% of UniSuper Management's portfolio in Q3 2026, its #130 holding.
- UniSuper Management first reported a position in ResMed in Q2 2023 and has held it in 14 quarters since.
- 280 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on UniSuper Management's 13F filing for Q3 2026, filed 26 Oct 2026.